Brief: Immucell Announces Preliminary Results For The Year Ended Dec. 31, 2022
09/01/2023 22:16
Jan 9 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES PRELIMINARY, UNAUDITED SALES RESULTS
FOR THE
YEAR ENDED DECEMBER 31, 2022
* IMMUCELL CORP - CONTINUE TO WORK TO ACHIEVE REGULATORY
APPROVAL
TO COMMERCIALIZE RE-TAIN
* IMMUCELL CORP - EXPECT TO MAKE THIRD SUBMISSION OF CMC
TECHNICAL
SECTION DURING Q1 OF 2023
* IMMUCELL CORP - DURING TWELVE-MONTH PERIODS ENDED DECEMBER
31,
2022 PRELIM UNAUDITED TOTAL SALES OF $18.57 MILLION
Source text for Eikon: ID:nGNXbKmjRS
Further company coverage: ICCC.O
((reuters.briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year